NANOTRANSMED enables french, german and swiss scientists to develop together applications and innovations in nanomedicine, meeting major issues regarding patients’ care. The consortium focuses in particular on issues concerning early, reliable and fast diagnosis but also personalized treatment of diseases such as cancers and inflammation as well as issues regarding nosocomial infections contracted by 5% of hospitalized patients. The project is cofinanced by the INTERREG VA Upper Rhine programme.